Nivaan Care Raises $7 Million in Series A Funding Led by Sorin Investments
Introduction
India’s healthcare landscape is witnessing a growing demand for specialized, patient-centric care, especially in areas that have long remained fragmented. One such segment is chronic pain management, affecting millions across the country. Addressing this gap, Nivaan Care, a single-specialty interventional pain management clinic chain, has raised $7 million in a Series A funding round, marking a significant milestone in its journey to scale evidence-based, minimally invasive pain treatment across India.
About the Funding
The Series A round was led by Sorin Investments, with continued participation from existing investors W Health Ventures, Endiya Partners, and Rebright Partners. This latest fundraise follows Nivaan Care’s $4.25 million seed round in February 2025, which was led by Endiya Partners along with W Health Ventures. The continued backing from existing investors reflects strong confidence in the startup’s clinical model, execution capabilities, and long-term vision.
Use of Funds
Nivaan Care plans to deploy the fresh capital across three core areas. First, the company will expand its clinic network across multiple Indian cities, strengthening its physical presence in both metro and select satellite markets. Second, it aims to enhance clinical and operational infrastructure, ensuring standardized care delivery and scalable operations. Third, the funding will support continued innovation in minimally invasive pain management procedures, improving patient outcomes while reducing dependency on surgery.
About the Startup
Founded in 2023, Nivaan Care operates single-specialty clinics dedicated to treating chronic pain conditions such as back pain, knee pain, neck pain, and joint-related disorders. Unlike traditional care pathways that oscillate between basic physiotherapy and invasive surgery, Nivaan positions itself as an evidence-led, non-surgical alternative focused on minimally invasive interventions. The company follows a multidisciplinary care model, integrating interventional pain physicians, physiotherapists, psychologists, nutritionists, and care coordinators to deliver personalized treatment plans.
Founders and Origin Story
Nivaan Care was founded by Nivesh Khandelwal (Co-founder & CEO) and Vishwas Singh (Co-founder & COO). Khandelwal previously served as COO at Ridge IVF, where he gained experience in scaling healthcare platforms, while Singh has held leadership roles at companies such as Tata 1mg and Shuttl. The founders identified chronic pain management as a large yet underserved market in India, with limited access to specialized interventional care. Their vision was to build a dedicated “middle layer” of care—bridging the gap between physiotherapy and surgery—through standardized clinics and clinical excellence.
Market Opportunity
Chronic pain affects nearly one in five adults in India, translating to an estimated 270 million people. Despite the scale of the problem, interventional pain management remains a nascent specialty in the country. India currently has fewer than 200 interventional pain clinics, compared to 4,000–5,000 clinics in the United States. This stark gap highlights the massive opportunity for organized, scalable players like Nivaan Care to build nationwide infrastructure and redefine pain treatment standards.
Business Model and Revenue Streams
Nivaan Care operates a clinic-led healthcare delivery model, generating revenue through patient consultations, diagnostic evaluations, and minimally invasive procedures such as radiofrequency ablation and platelet-rich plasma therapy. The company emphasizes standardized protocols, clinical outcomes, and patient experience, enabling repeat visits and long-term care relationships. Its full-stack model allows tight control over quality, pricing transparency, and operational efficiency, which is critical for scaling specialty healthcare services.
Traction and Current Presence
The startup currently operates clinics across Delhi-NCR, Mumbai, Jaipur, and Lucknow, serving both metro and satellite markets. To date, Nivaan Care has completed over 40,000 patient consultations and conducted approximately 5,000 minimally invasive procedures. According to the company, a significant proportion of patients report noticeable pain reduction and improved daily functioning, reinforcing the effectiveness of its multidisciplinary approach.
Future Plans
With the Series A capital, Nivaan Care plans to enter new markets such as Bengaluru and further strengthen its operational backbone. Over the next 4–5 years, the company aims to scale from around 15 clinics to 60–75 centers nationwide, building India’s first large-scale platform for interventional pain management. The focus will remain on execution excellence, standardized systems, and seamless patient journeys across locations.
Conclusion
Nivaan Care’s Series A funding marks an important step toward addressing one of India’s most widespread yet under-served healthcare challenges. By combining clinical expertise, minimally invasive treatments, and a scalable clinic model, the startup is positioning itself as a category-defining player in interventional pain management. With strong investor backing and a clear expansion roadmap, Nivaan Care is well-placed to transform how chronic pain is treated across India.
At Angeltors, we track high-potential startups shaping the future of healthcare, consumer services, and technology-led platforms. From early signals to growth-stage funding, we help investors understand where smart capital is moving and why it matters.
Follow Angeltors for more curated startup funding insights, deep dives, and emerging opportunities from India’s startup ecosystem.
GetMyIndia.com Angeltors.com RaysVeda.com LawCanal.com ABHAYRAY.COM
Read more - https://angeltors.com/post/dot-key-35
